Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
Sandra Le Guyader-Peyrou, Sébastien Orazio, Olivier Dejardin, Marc Maynadié, Xavier Troussard, Alain Monnereau
Haematologica March 2017 102: 584-592; doi:10.3324/haematol.2016.152918

Author Affiliations

  1. Sandra Le Guyader-Peyrou1,2⇑,
  2. Sébastien Orazio1,2,
  3. Olivier Dejardin3,
  4. Marc Maynadié4,
  5. Xavier Troussard5,6 and
  6. Alain Monnereau1,2
  1. 1Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France
  2. 2University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  3. 3University Hospital of Caen, U1086 INSERM UCBN «Cancers & Préventions», France
  4. 4Registre des Hémopathies Malignes de Côte d’Or, EA4184, Université de Bourgogne, Dijon, France
  5. 5Registre des Hémopathies Malignes de Basse Normandie, Caen, France
  6. 6Laboratoire d’Hématologie, CHU de Caen, France
  1. Correspondence
    : s.leguyaderpeyrou{at}bordeaux.unicancer.fr
View Abstract

Article Information

vol. 102 no. 3 584-592
DOI 
https://doi.org/10.3324/haematol.2016.152918
PubMed 
27909221
Published By 
Haematologica
Print ISSN 
0390-6078
Online ISSN 
1592-8721
History 
  • Received July 19, 2016
  • Accepted November 24, 2016
  • .

Article Versions

Copyright & Usage 
Copyright© Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

Author Information

  1. Sandra Le Guyader-Peyrou1,2⇑,
  2. Sébastien Orazio1,2,
  3. Olivier Dejardin3,
  4. Marc Maynadié4,
  5. Xavier Troussard5,6 and
  6. Alain Monnereau1,2
  1. 1Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France
  2. 2University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, F-33000, France
  3. 3University Hospital of Caen, U1086 INSERM UCBN «Cancers & Préventions», France
  4. 4Registre des Hémopathies Malignes de Côte d’Or, EA4184, Université de Bourgogne, Dijon, France
  5. 5Registre des Hémopathies Malignes de Basse Normandie, Caen, France
  6. 6Laboratoire d’Hématologie, CHU de Caen, France
  1. Correspondence
    : s.leguyaderpeyrou{at}bordeaux.unicancer.fr
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: December 2016 to July 2019

AbstractFullPdf
Dec 2016239079
Jan 201788022
Feb 201774638
Mar 201722268107
Apr 2017824837
May 20176196128
Jun 20174224225
Jul 20171114420
Aug 201718827
Sep 201785422
Oct 201747016
Nov 201763512
Dec 201720469
Jan 2018194012
Feb 201893616
Mar 2018144511
Apr 20182324
May 201834710
Jun 201885810
Jul 20183392
Aug 20183378
Sep 20180265
Oct 201814217
Nov 201824212
Dec 20181577
Jan 20193648
Feb 201911627
Mar 20190614
Apr 201903010
May 201945319
Jun 201924417
Jul 201974616
Back to top
Email
Print
Citation Tools

Jump To

What about you?
Tell us your interests and get all the new contents of Haematologica in advance